Meta-analysis of 719 clinical prostate cancer tumours from 11 previously published studies detected significant up-regulation of both ESRP1 and ESRP2 in 9/11 datasets (Figure 2—source data 1) (Arredouani et al., 2009; Cancer Genome Atlas Research Network, 2015; Fraser et al., 2017; Grasso et al., 2012; Lapointe et al., 2004; Liu et al., 2006; Luo et al., 2002; Taylor et al., 2010; Tomlins et al., 2007; Vanaja et al., 2003; Varambally et al., 2005; Wallace et al., 2008). Here, ESRP2 is linked to neoplasm.